A simple assay for tumor necrosis factor using HEp-2 target cells

Area of Science:

• Oncology
• Immunology
• Cell Biology

Background:

• Tumor Necrosis Factor-alpha (TNF) plays a critical role in inflammatory and immune responses.
• Accurate quantification of TNF is essential for understanding its role in diseases like cancer.
• Existing bioassays may lack sensitivity or specificity for TNF determination.

Purpose of the Study:

• To develop and validate a sensitive bioassay for the determination of tumor necrosis factor-alpha (TNF).
• To utilize HEp-2 adherent human epipharynx carcinoma cells as target cells for TNF detection.
• To characterize the specificity of the developed bioassay against other cytokines.

Main Methods:

• Development of a bioassay using HEp-2 cells as targets.
• Stimulation of human monocytes with lipopolysaccharide (LPS) to induce TNF production.
• Quantification of TNF-like activity via a 24-hour 3H-thymidine incorporation assay.
• Assessment of HEp-2 cell detachment as an indicator of cytotoxicity.

Main Results:

• The bioassay demonstrated sensitive and reproducible detection of TNF-like activity.
• TNF-like activity induced cell destruction, evidenced by inhibition of thymidine incorporation and cell detachment.
• HEp-2 cells showed insensitivity to interleukin-1 (IL-1) and interleukin-2 (IL-2).
• While interferons were cytotoxic, LPS-stimulated monocyte supernatants lacked detectable interferon levels.

Conclusions:

• A sensitive bioassay for TNF determination using HEp-2 cells was successfully developed.
• The assay effectively measures TNF-induced cytotoxicity and cell detachment.
• The HEp-2 cell-based assay provides a specific method for TNF detection, distinguishing it from IL-1, IL-2, and interferons in this context.